Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole Add-on for Cesarean Scar Pregnancy
NCT05839574Completed
- Sponsor
- Jagiellonian University
- Start
- Jan 2021
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of letrozole in cesarean scar pregnancy (CSEP) (2 arms), sponsored by Jagiellonian University. Primary endpoints: Blood loss during the procedure expressed as a decrease in hemoglobin concentration up to 6 months, Blood loss volume during the procedure expressed in volume units up to 6 months and 1 more. Started Jan 2021; status: completed.
02
Drugs
letrozole
03
Conditions
cesarean scar pregnancy (CSEP)
Beyond the preview
Go deeper on NCT05839574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05839574.